MINISO, PDF Solutions, and Certara are small stocks with strong price momentum. It’s not unusual for small stocks to show more price momentum than larger peers.
Xentria, Inc., a biotech company focused on developing treatments to address unmet clinical needs, today announced the peer reviewed publication in Frontiers in Pharmacology of a biosimulation model...
The company, which helps other companies in their drug development, reported strong third-quarter numbers.
CERT earnings call for the period ending June 30, 2022.
Biosimulation software and services fuel second quarter growth...
New automation, analytics and collaboration features save time and ensure regulatory compliance...
PRINCETON, N.J., July 25, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of...
Advances lead optimization, first-in-human dose prediction and formulation development...
New capabilities enhance clinical predictability for different compounds across more therapeutic areas...
CERT earnings call for the period ending March 31, 2022.